Johnson & Johnson Q2 Adjusted EPS $2.80 Beats $2.62 Estimate, Sales $25.53B Beat $24.63B Estimate
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson (NYSE:JNJ) reported Q2 earnings of $2.80 per share, beating the analyst consensus estimate of $2.62 by 6.87%. This is an 8.11% increase from the same period last year. The company also reported quarterly sales of $25.53 billion, beating the analyst consensus estimate of $24.63 billion by 3.65%. This is a 6.29% increase from the same period last year.
July 20, 2023 | 10:21 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Johnson & Johnson's Q2 earnings and sales beat analyst estimates, indicating a strong financial performance.
Johnson & Johnson's Q2 earnings and sales exceeded analyst estimates, which is a positive signal for the company's financial health. This could lead to increased investor confidence and potentially a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100